Nuvation Bio (NUVB) Competitors $3.16 -0.10 (-3.07%) Closing price 03:59 PM EasternExtended Trading$3.18 +0.02 (+0.79%) As of 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NUVB vs. TGTX, MRUS, CRSP, PTCT, KRYS, PCVX, ACAD, ACLX, ADMA, and ARWRShould you be buying Nuvation Bio stock or one of its competitors? The main competitors of Nuvation Bio include TG Therapeutics (TGTX), Merus (MRUS), CRISPR Therapeutics (CRSP), PTC Therapeutics (PTCT), Krystal Biotech (KRYS), Vaxcyte (PCVX), ACADIA Pharmaceuticals (ACAD), Arcellx (ACLX), ADMA Biologics (ADMA), and Arrowhead Pharmaceuticals (ARWR). These companies are all part of the "pharmaceutical products" industry. Nuvation Bio vs. Its Competitors TG Therapeutics Merus CRISPR Therapeutics PTC Therapeutics Krystal Biotech Vaxcyte ACADIA Pharmaceuticals Arcellx ADMA Biologics Arrowhead Pharmaceuticals Nuvation Bio (NYSE:NUVB) and TG Therapeutics (NASDAQ:TGTX) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, institutional ownership, analyst recommendations, risk and media sentiment. Which has more risk & volatility, NUVB or TGTX? Nuvation Bio has a beta of 1.36, suggesting that its share price is 36% more volatile than the S&P 500. Comparatively, TG Therapeutics has a beta of 1.88, suggesting that its share price is 88% more volatile than the S&P 500. Does the media refer more to NUVB or TGTX? In the previous week, TG Therapeutics had 14 more articles in the media than Nuvation Bio. MarketBeat recorded 16 mentions for TG Therapeutics and 2 mentions for Nuvation Bio. Nuvation Bio's average media sentiment score of 1.63 beat TG Therapeutics' score of 0.73 indicating that Nuvation Bio is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nuvation Bio 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive TG Therapeutics 9 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders believe in NUVB or TGTX? 61.7% of Nuvation Bio shares are owned by institutional investors. Comparatively, 58.6% of TG Therapeutics shares are owned by institutional investors. 29.9% of Nuvation Bio shares are owned by company insiders. Comparatively, 10.6% of TG Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has preferable earnings & valuation, NUVB or TGTX? TG Therapeutics has higher revenue and earnings than Nuvation Bio. Nuvation Bio is trading at a lower price-to-earnings ratio than TG Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNuvation Bio$7.87M137.43-$567.94M-$0.63-5.02TG Therapeutics$454.07M11.39$23.38M$0.3788.14 Is NUVB or TGTX more profitable? TG Therapeutics has a net margin of 13.31% compared to Nuvation Bio's net margin of -1,413.43%. TG Therapeutics' return on equity of 26.05% beat Nuvation Bio's return on equity.Company Net Margins Return on Equity Return on Assets Nuvation Bio-1,413.43% -46.14% -36.04% TG Therapeutics 13.31%26.05%9.58% Do analysts rate NUVB or TGTX? Nuvation Bio presently has a consensus price target of $7.50, indicating a potential upside of 137.34%. TG Therapeutics has a consensus price target of $48.00, indicating a potential upside of 47.19%. Given Nuvation Bio's stronger consensus rating and higher possible upside, equities analysts plainly believe Nuvation Bio is more favorable than TG Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nuvation Bio 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.17TG Therapeutics 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80 SummaryTG Therapeutics beats Nuvation Bio on 9 of the 17 factors compared between the two stocks. Get Nuvation Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for NUVB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NUVB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NUVB vs. The Competition Export to ExcelMetricNuvation BioMED IndustryMedical SectorNYSE ExchangeMarket Cap$1.12B$3.12B$5.76B$21.58BDividend YieldN/A2.37%5.74%3.49%P/E Ratio-5.0221.2276.8630.17Price / Sales137.43459.47539.9454.74Price / CashN/A45.3237.1724.62Price / Book2.319.6913.834.58Net Income-$567.94M-$52.92M$3.29B$1.00B7 Day Performance-5.67%1.44%0.93%0.88%1 Month Performance8.97%6.03%5.31%5.45%1 Year Performance8.97%12.89%84.25%15.94% Nuvation Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NUVBNuvation Bio2.8749 of 5 stars$3.16-3.1%$7.50+137.3%+6.5%$1.12B$7.87M-5.0260Gap DownTGTXTG Therapeutics4.3823 of 5 stars$32.38+0.5%$46.25+42.8%+27.8%$5.11B$329M87.51290News CoverageAnalyst ForecastAnalyst RevisionMRUSMerus3.0622 of 5 stars$67.19-0.4%$88.75+32.1%+36.1%$5.10B$36.13M-12.2237Positive NewsAnalyst ForecastCRSPCRISPR Therapeutics3.0994 of 5 stars$54.10-1.4%$71.60+32.3%+18.4%$4.99B$37.31M-9.96460News CoverageAnalyst ForecastGap UpPTCTPTC Therapeutics3.7539 of 5 stars$56.95-0.5%$69.00+21.2%+72.9%$4.55B$806.78M8.171,410Insider TradeKRYSKrystal Biotech4.9534 of 5 stars$145.20-3.4%$210.38+44.9%-18.6%$4.35B$290.52M29.51210Analyst ForecastPCVXVaxcyte2.2295 of 5 stars$32.41-1.8%$130.00+301.1%-73.5%$4.29BN/A0.00160Positive NewsGap UpACADACADIA Pharmaceuticals4.291 of 5 stars$25.39+0.5%$28.88+13.7%+48.8%$4.26B$957.80M19.09510ACLXArcellx2.1452 of 5 stars$71.11-2.1%$114.31+60.7%-2.0%$4.03B$107.94M0.0080ADMAADMA Biologics3.5503 of 5 stars$16.42-2.7%$27.67+68.5%-16.8%$4.03B$426.45M19.09530Positive NewsARWRArrowhead Pharmaceuticals4.1618 of 5 stars$27.17-6.6%$43.14+58.8%+45.6%$4.02B$3.55M-21.23400Trending NewsInsider TradeAnalyst RevisionGap Up Related Companies and Tools Related Companies TG Therapeutics Alternatives Merus Alternatives CRISPR Therapeutics Alternatives PTC Therapeutics Alternatives Krystal Biotech Alternatives Vaxcyte Alternatives ACADIA Pharmaceuticals Alternatives Arcellx Alternatives ADMA Biologics Alternatives Arrowhead Pharmaceuticals Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:NUVB) was last updated on 9/18/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredRecession Risk: 90% — Are Your Savings Ready?Moody's latest report shows one-third of U.S. economic activity is already in recession or at high risk.Lear Capital | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredThe dollar is failing – here’s your escapeSilver’s 100X Run Is Coming? All gold bull markets follow the same pattern. First, gold moves up. Then majo...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuvation Bio Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuvation Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
